Skip to content

A study on Vasu Suvarnaprashan Drops in improving immunity in children.

A clinical study to assess the efficacy & safety of Vasu Suvarnaprashan Drops in children - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078615
Enrollment
30
Registered
2024-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Vasu Swarnaprashan Drops: 3 drops of Vasu Suvarnaprashan drops daily for 90 days. Control Intervention1: NIL: NIL

Sponsors

Vasu Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children Aged 0-16 years inclusive (both gender) Participants will be equally distributed to age range from 0-5 years (Both inclusive) 5 plus to 10 years (Both inclusive) and 10 plus to 16 years (Both inclusive) that is 10 participants in each category. 2.Parents or guardians understand and are willing, able and likely to comply with all study procedures and restrictions.

Exclusion criteria

Exclusion criteria: 1.Participant has a known allergy or intolerance to the study product or ingredients or is on a special diet and cannot consume the study product. 2.The participant has an ongoing illness requiring medical management. 3.The participant has a gastrointestinal infection and or acute diarrhea at the time of inclusion in the study. 4.The participant is currently taking medication that could affect the absorption or metabolism of the study product or the weight of the child. 5.The participant is diagnosed with recurrent respiratory infections due to cystic fibrosis, immunodeficiency syndromes congenital abnormalities of the respiratory tract congenital lung and ciliary abnormalities, an unsuspected foreign body and asthma (As per history and or the medical records). 6.Any other condition that could interfere with the study outcomes as per the discretion of the investigator will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
1.Changes in physical growth parameters •Anthropometric parameters like height, body weight upper arm & chest circumference, and BMI.Timepoint: screening, day 30, day 60, and day 90.

Secondary

MeasureTime frame
1.Effect on Immunological parameters like- •Serum Immunoglobulin A, G levels •Changes in frequency severity and recovery of URTI 2.cardiorespiratory fitness- VO2 and Pre-school adapted 20m Shuttle run test (PREFIT). 3.Learning ability memory and concentration- Questionnaire for Evaluation of Development and Behaviour (Parent version)- Attention and concentration memory reading writing arithmetic learning new things and applying knowledge in school domain scores will be analyzed. 4.Quality of sleep- Pittsburgh Sleep Quality Index (PSQI) will be assessed. 5.Change in appetite score using the child eating behaviour questionnaire (CEBQ). 6.Parent or Guardian reported an overall improvement in child growth and development after treatment on the 5-point Likert scale. Timepoint: screening and end of the study screening, day 30, day 60, and day 90. screening and day 90 (Only for groups B and C) screening and day 90 screening and day 90 screening, day 30, day 60, and day 90 day 90

Countries

India

Contacts

Public ContactDr Hardik Soni

Vasu Healthcare Pvt Ltd

hsoni@vasuresearch.com9428692240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026